LONDON: The World Health Organisation was seeking clarification from New Delhi on whether a cough syrup linked to deaths in India has been exported to other countries, the global health agency said on Wednesday.

The WHO said it will assess the need for a Global Medical Products Alert on Coldrif syrup once it receives official confirmation from the Indian authorities.

At least 17 children younger than five years old have died in India in the past month after consuming cough medicine that contained the toxic compound diethylene glycol in quantities nearly 500 times the permissible limit, officials say.

Published in Dawn, October 9th, 2025

Opinion

Editorial

UAE’s Opec exit
30 Apr, 2026

UAE’s Opec exit

THE UAE’s exit from Opec is another sign of the major geopolitical shifts that are reshaping the global order. One...
Uncertain recovery
30 Apr, 2026

Uncertain recovery

PAKISTAN’S growth projections for the current fiscal present a cautiously hopeful picture, though geopolitical...
Police ‘encounters’
30 Apr, 2026

Police ‘encounters’

THE killing of nine suspects by Punjab’s Crime Control Department across Lahore, Sahiwal and Toba Tek Singh ...
Growth to stability
Updated 29 Apr, 2026

Growth to stability

THE State Bank’s decision to raise its key policy rate by 100 basis points to 11.5pc signals a shift in priorities...
Constitutional order
29 Apr, 2026

Constitutional order

FOLLOWING the passage of the 26th and 27th Amendments, in 2024 and 2025 respectively, jurists and members of the...
Protecting childhood
29 Apr, 2026

Protecting childhood

AN important victory for child protection was secured on Monday with the Punjab Assembly’s passage of the Child...